Physician profile
Joelle Yates
NPI 1164069837
$1,401.56
in general payments reported to CMS, 2019-2025
20 companies · $199 in 2025
The $199 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $495 · 2022: $126 · 2023: $322 · 2024: $260 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $781.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $780.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $336.14 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $153.16 | 2021-2025 | |
| Shield Therapeutics INC | $144.28 | 2023-2024 | Accrufer |
| Exeltis, USA INC. | $133.48 | 2021-2025 | Slynd |
| Organon LLC | $130.90 | 2021-2024 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $101.71 | 2021-2025 | |
| Abbvie INC. | $81.64 | 2021 | |
| Dexcom, INC. | $56.33 | 2024-2025 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $36.63 | 2023-2024 | Veozah |
| Coopersurgical, INC. | $33.82 | 2023 | Paragard T 380a |
| Pfizer INC. | $32.01 | 2024-2025 | |
| Amgen INC. | $26.50 | 2023-2024 | Evenity, Prolia |
| Biogen, INC. | $25.56 | 2025 | Zurzuvae |
| Baxter Healthcare | $22.47 | 2024 | Tisseel |
| Gynesonics, INC. | $17.15 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $15.61 | 2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $14.89 | 2024 | Gardasil, Gardasil 9 |
| Hologic Sales and Service, LLC | $13.91 | 2023 | Acessa Provu System |
| Mylan Pharmaceuticals INC. | $13.30 | 2021 | |
| Lupin INC. | $12.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joelle Yates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.